Novo Nordisk and Lilly are likely to command a significant share of the market for years to come, with Morningstar projecting the companies would retain 80-90% or more of the GLP-1 market share for the foreseeable future
Medications such as retatrutide, which affect multiple hormone pathways, GLP-1, GIP, and glucagon, could potentially provide quicker or more dramatic effects than single-pathway counterparts
no oral tirzepatide is available You want a longer track record, as semaglutide has been on the market since 2017 with more long-term safety data Insurance or cost favors it, so check your specific plan coverage for both options You prefer more stable blood levels, as semaglutide's longer half-life (~7 days vs ~5 days) means less fluctuation between doses Switching Between Tirzepatide and Semaglutide Switching from one to the other is common
Can Glycolic Acid Help Your Underarms
Connect with real prescribers from home 92% of customers saw improvement by their second check-in *Actual results may vary
Rizzoli, Genve (Ostoporose)